G. Melanophy

Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin

C. Merry, E. Relihan, C. Bergin, 2020, British journal of clinical pharmacology.

NP-018 Building capacity within a Hepatitis C treatment model. The validation process for a Hepatitis C pre-treatment pharmacist assessment complex intervention toolkit

S. Norris, C. Bergin, A. O'Leary, 2021, National poster prize winners.

Delayed haemolysis after IV artesunate therapy for P. falciparum infection

C. Merry, Ròisìn O'Connor, C. Bergin, 2022, Travel Medicine and Infectious Disease.

Transition to ePrescribing for systemic anti-cancer therapy - Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital.

H. O'Connor, M. Flattery, G. Melanophy, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Pharmacist-led pre-treatment assessment, management and outcomes in a Hepatitis C treatment patient cohort

S. Norris, C. Bergin, A. O'Leary, 2019, International Journal of Clinical Pharmacy.